> A study in the U.S. has tied a 13% drop in cancer-free survival rates in young patients with Hodgkin lymphoma to a shortage of a cancer medication. Story
> Maine Manufacturing says it has bought the Whatman line of laboratory products, which includes a variety of filters and ready-to-use liquid growth media, from GE Healthcare. Release
> Teva Pharmaceutical Industries ($TEVA) has added a dose counter to its ProAir asthma medication. Release
> Pakistan drugmakers are pledging not to buy APIs from India, even saying they will pay more for active ingredients to get them from European suppliers. Story
> Greece is investigating claims that some drug shortages in the country are the result of market manipulation. Story
> Parexel International ($PRXL) will pay $72 million to buy software firm Liquent, whose products support regulatory submissions and product registrations. Story
> AAIPharma Services is expanding its Charleston, SC, parenteral manufacturing facility to include compounding and aseptic processing suites to contain a newly acquired Monoblock vial-filling machine, as well as other additions. Item
> India's Dr. Reddy's Laboratories is now selling exclusively for 180 days a generic bioequivalent of the baldness drug Propecia from Merck ($MRK). Release
And Finally... The Los Angeles Police Department says it has arrested 6 members of what it refers to as "an Armenian organized" cargo theft ring but is asking the public to provide more information about the gang, which it says has stolen containers of pharmaceuticals, as well as other products. Release